OSTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OS Therapies Inc (OSTX) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of strong positive catalysts, insider selling, weak financial performance, and absence of trading signals suggest holding off on this stock for now.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 70.707, and moving averages are converging, showing no clear trend. The pre-market price of $1.48 is near the R1 resistance level of $1.465, suggesting limited immediate upside potential.
The MACD indicates bullish momentum, and the stock is trading near a key resistance level, which may attract short-term traders.
Insiders are selling, with a 100.96% increase in selling activity over the last month. Financial performance remains weak, with negative net income and declining EPS. Analysts have lowered the price target due to recent dilution.
In Q4 2025, revenue remained at $0 with no growth YoY. Net income improved but remains negative at -$13,460,833. EPS dropped by -2.50% YoY, reflecting continued financial struggles.
Lake Street maintains a Buy rating but has lowered the price target from $17 to $14 due to recent dilution and capital activity.
